Summary
The product Thyromed 50, manufactured by Deus Medical, underwent independent testing to verify its potency and authenticity. The sample, identified by batch number DM64669, was submitted by DEUSPOWER.COM and analyzed by Janoshik Analytical. The analysis confirmed the presence of T4 (thyroxine), with measured concentrations of 47.93 mcg and 49.31 mcg in two separate pills, closely aligning with the labeled 50 mcg dosage.
The testing process began on 7 July 2020, with the sample received on 7 July 2020, and analysis completed on 9 July 2020. While the results confirm accurate dosing, further independent testing is recommended to ensure product consistency across different batches.
Detailed Report
Product Overview
- Manufacturer: Deus Medical
- Product Name: Thyromed 50
- Active Ingredient: T4 (Thyroxine)
- Batch Number: DM64669 (Manufactured: 05/2020)
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #07055
- Testing Ordered: 7 July 2020
- Sample Received: 7 July 2020
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DEUSPOWER.COM
- Analysis Paid For By: DEUSPOWER.COM
Testing Results
- Specification: 50 mcg (as stated on the label)
- Measured Concentration: 47.93 mcg & 49.31 mcg
- Accuracy: 95.86% % 98.62% of the label claim
Verification Details
- Verification URL: https://janoshik.com/tests/07055_VZFAH9SXR4NI
Evaluation of Reseller-Submitted Testing
While this test confirms that the Thyromed 50 batch tested has a high level of accuracy, it is important to note that this sample was submitted and paid for by DEUSPOWER.COM, a reseller. Resellers may selectively test high-quality batches, which might not represent overall batch consistency.
For a full assessment of product reliability, additional third-party testing across multiple batches is recommended.
Conclusion
The analysis confirms that Thyromed 50 by Deus Medical is accurately dosed, with T4 levels close to the label claim. The small variance of 1.38% – 4.14% is within acceptable pharmaceutical limits, indicating strong manufacturing quality.
However, as the test was submitted by a reseller, further independent testing is advisable to confirm batch-to-batch consistency. Consumers should be mindful of possible variations over time.
This report serves as an educational resource to promote harm reduction and informed decision-making regarding T4-containing products.
Disclaimer
This report is published for educational and harm reduction purposes. While reseller-submitted testing may provide useful data, it is important to recognize the potential for bias.
Readers are encouraged to verify product quality through multiple independent sources before making purchasing decisions.
